California residents may have seen advertisements regarding the possible link between diabetic drug Actos and bladder cancer. In two separate states, plaintiffs are presenting evidence in cases that could build a foundation for global settlements with the maker of the drug. One case featured closing arguments on Monday, April 7. The other pharmaceutical litigation case resumed court proceedings following a two-week hiatus.
The case that resumed proceedings involves two women, ages 80 and 81. Both women accuse the company of hiding bladder cancer risks from patients and physicians. The women have diabetes and began taken Actos. Both allege that they developed bladder cancer after taking the medication.